Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

BLRX $1.28 0.2700 +26.73%
BDSI $2.70 0.2500 +10.20%
TRIL $15.99 1.3300 +9.07%
NLNK $12.87 0.8600 +7.16%
BLCM $20.57 1.2600 +6.53%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

MNKD $0.61 -0.0664 -9.75%
MRTX $5.88 -0.5800 -8.98%
CALA $3.00 -0.1800 -5.66%
GALT $2.73 -0.1400 -4.88%
MTP $3.11 -0.1400 -4.31%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 888 | 889 | 890 | 891 | 892 | 893 | 894 | 895 | 896 | 897 | Next > | Last >>

Heartburn Tied to Throat Cancer

(New York Times/Well blog) May 23, 2013 - Frequent heartburn increases the risk for throat cancer, a new study has found, and over-the-counter antacids may provide protection.
read article 

Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE sNDA in Advanced Pancreatic Cancer

(MarketWatch) May 23, 2013 - Celgene International Sarl, a subsidiary of Celgene Corporation today announced that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to the supplemental New Drug Application (sNDA) for the use of ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for the first-line treatment of patients with advanced pancreatic cancer.
read article 

NICE Finds Advanced Ovarian Cancer Treatment Too Expensive With Not Enough Benefit

(NICE) May 22, 2013 - The National Institute for Health and Care Excellence (NICE) has advised the NHS against funding the drug bevacizumab (Avastin, manufactured by Roche) for advanced ovarian cancer.
read press release 

Pfizer to Spin Off Remaining Zoetis Stake

(Fox Business/Dow Jones Newswires) May 22, 2013 - Pfizer Inc. plans to split off its remaining interest in its former animal-medicine unit Zoetis Inc. through a voluntary exchange offer with its shareholders.
read article 

Amag Investigates Anemia Drug After Report of Death in Switzerland

(Reuters) May 21, 2013 - Amag Pharmaceuticals Inc said its marketing partner in Switzerland, Takeda Pharmaceutical Co Ltd, is recalling a batch of Amag's anemia drug, Rienso, because of a death and several cases of hypersensitivity.
read article 

Glaxo to Get Up to $200 Million for U.S. Research

(Bloomberg) May 22, 2013 - GlaxoSmithKline Plc, the U.K.'s largest drugmaker, will work with the U.S. government to develop antibiotics for resistant infections and bioterrorist threats in an agreement valued at as much as $200 million.
read article 

Electronic Health Data Gaining Favor

(Wall Street Journal) May 22, 2013 - More than half of U.S. doctors have switched to electronic health records and are using them to manage patients' basic medical information and prescriptions.
read article (paid subscription required) 

Wall Street's A-List Turns Out to Fight Skin Cancer

(New York Times/DealBook blog) May 22, 2013 - Jeffrey Rowbottom, a managing director at Kohlberg Kravis Roberts, was greeting guests Tuesday evening at a charity event at the Sea Grill in Rockefeller Center, when one issued a challenge.
read article (paid subscription required) 

The Way We Think About Cancer Must Evolve

(Wired) May 22, 2013 - The longer you live, the more chances for a distorted, pernicious cell to elude the body's defenses and develop into full-blown cancer.
read article 

American Cancer Society, Born at a Time When Cancer Was a Lesser Threat, Marks 100 Years

(Washington Post/Associated Press) May 22, 2013 - The American Cancer Society - one of the nation's best known and influential health advocacy groups - is 100 years old this week.
read article (free registration required) 

Dallas Philanthropist Lyda Hill Gives $50 Million to M.D. Anderson Cancer Initiative

(Dallas Morning News) May 21, 2013 - Dallas philanthropist Lyda Hill has pledged $50 million to the University of Texas M.D. Anderson Cancer Center, the Houston institution announced Tuesday.
read article 

Lehigh Valley Health Network Joins the Moffitt Oncology Network

(Lehigh Valley Health Network) May 21, 2013 - Lehigh Valley Health Network is partnering with Moffitt Cancer Center to enhance cancer care by joining the newly launched Moffitt Oncology Network. Lehigh Valley, based in Allentown, Pa., is the first member of the network outside of Florida.
read press release 

Empire Genomics Licenses Biomarker from Cornell to Develop Prostate Cancer Dx

(GenomeWeb News) May 22, 2013 - Empire Genomics today announced it has licensed a genomic biomarker from Cornell University for the development of a test to diagnose and determine treatment of patients with neuroendocrine prostate cancer, or NEPC.
read article 

Mayo Clinic, Cancer Genetics Form Diagnostics JV

(Genetic Engineering News) May 22, 2013 - Mayo Clinic will join with Cancer Genetics to develop and commercialize cancer diagnostics based on next-generation sequencing through a new joint venture.
read article 

Given Imaging Study May Help Approval: Israel Overnight

(Bloomberg) May 22, 2013 - Results from Given Imaging Ltd.'s latest clinical study of a pill-sized camera used to identify colon cancer probably will help the Israeli manufacturer secure U.S. regulatory approval this year, Chief Executive Officer Homi Shamir said.
read article 

Two in Three Cancer Patients Are Non-Adherent With Their Medications, According to Kantar Health Research

(Albany Times-Union) May 21, 2013 - Two-thirds of patients who have been diagnosed with leukemia, melanoma or non-small cell lung cancer reported that they engage in at least one type of non-adherent behavior in their medicine use, according to new findings from the National Health and Wellness Survey (NHWS), conducted by Kantar Health.
read article 

Transgene Announces Completion of Enrollment in TRAVERSE, a Phase 2b Clinical Trial of Pexa-Vec for the Treatment of Liver Cancer

(Transgene) May 21, 2013 - Transgene SA, a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in cancer and chronic infectious diseases, today announced completion of enrollment in the 120-patient TRAVERSE study.
read corporate press release 

Why Stomach Cancer is Declining in the US

(dailyRx News) May 21, 2013 - A type of stomach cancer called intestinal-type noncardia gastric adenocarcinoma (NCGA) is on a steep decline in the US, according to a recent review.
read article 

New Prostate Cancer Test Designed to Use Urine Instead of Blood

(KPCC Public Radio 89.3 [Pasadena, CA]) May 22, 2013 - A team of researchers at UC Irvine are developing a what it hopes will be a more reliable prostate cancer test that uses urine instead of blood.
read article 

Beta-Blockers May Boost Chemo Effect in Childhood Cancer

(Cancer Research UK/British Journal of Cancer) May 22, 2013 - Beta-blockers, normally used for high blood pressure, could enhance the effectiveness of chemotherapies in treating neuroblastoma, a type of children's cancer, according to a new study published in the British Journal of Cancer, today (Wednesday).
read press release 

Poliovirus Vaccine Trial Shows Early Promise for Recurrent Glioblastoma

( May 21, 2013 - An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.
read press release 

Research Offers Promising New Approach to Treatment of Lung Cancer

(Oregon State) May 22, 2013 - Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage done to other organs while significantly improving the treatment of lung tumors.
read press release 

Low-Dose CT Scans May Help Spot Early Lung Cancer

(WebMD/HealthDay News) May 21, 2013 - Finding early signs of lung cancer was once next to impossible, but a new study adds to a growing body of evidence suggesting that screening with low-dose CT scans may help spot the beginnings of disease in high-risk patients.
read article 

Oncolytics Cancer Drug Meets Mid-Stage Trial Goal, Shares Rise

(Reuters) May 22, 2013 - Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main goal of reducing the size of tumors in patients with metastatic melanoma, a type of skin cancer.
read article 

Medicare Nixes Coverage For New Cancer Tests

(Forbes) May 22, 2013 - Medicare has sharply changed the way it pays for diagnostic tests, cutting payment rates and curtailing coverage for some new tests altogether.
read article